摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Benzyl 4-[2-(4-cyanophenyl)-4-oxo-5,10-dihydrofuro[2,3-c][1]benzazepin-8-yl]piperazine-1-carboxylate | 1357089-54-3

中文名称
——
中文别名
——
英文名称
Benzyl 4-[2-(4-cyanophenyl)-4-oxo-5,10-dihydrofuro[2,3-c][1]benzazepin-8-yl]piperazine-1-carboxylate
英文别名
benzyl 4-[2-(4-cyanophenyl)-4-oxo-5,10-dihydrofuro[2,3-c][1]benzazepin-8-yl]piperazine-1-carboxylate
Benzyl 4-[2-(4-cyanophenyl)-4-oxo-5,10-dihydrofuro[2,3-c][1]benzazepin-8-yl]piperazine-1-carboxylate化学式
CAS
1357089-54-3
化学式
C31H26N4O4
mdl
——
分子量
518.572
InChiKey
FSZVBZFHZCHVPJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    39
  • 可旋转键数:
    5
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    98.8
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Conformation constraint of anilides enabling the discovery of tricyclic lactams as potent MK2 non-ATP competitive inhibitors
    作者:Dong Xiao、Anandan Palani、Xianhai Huang、Michael Sofolarides、Wei Zhou、Xiao Chen、Robert Aslanian、Zhuyan Guo、James Fossetta、Fang Tian、Prashant Trivedi、Peter Spacciapoli、Charles E. Whitehurst、Daniel Lundell
    DOI:10.1016/j.bmcl.2013.03.109
    日期:2013.6
    Conformation restriction of linear N-alkylanilide MK2 inhibitors to their E-conformer was developed. This strategy enabled rapid advance in identifying a series of potent non-ATP competitive inhibitors that exhibited cell based activity in anti-TNF alpha assay. (C) 2013 Elsevier Ltd. All rights reserved.
  • Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitors
    作者:Ashwin U. Rao、Dong Xiao、Xianhai Huang、Wei Zhou、James Fossetta、Dan Lundell、Fang Tian、Prashant Trivedi、Robert Aslanian、Anandan Palani
    DOI:10.1016/j.bmcl.2011.11.113
    日期:2012.1
    Facile synthesis of two new series of tetracyclic azepine and oxazocine analogs is described. These analogs were evaluated for their potential as MAPKAP-K2 (MK2) inhibitors and several were found to be potent at inhibiting MK2 with a non-ATP competitive binding mode. Published by Elsevier Ltd.
查看更多